Table 2.
Liver functions in the study subjects
| Liver function | Before therapy | P | Therapy for 2 W | P | Therapy for 4 W | P | Therapy for 8 W | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||||||
| Experimental group | Control group | Experimental group | Control group | Experimental group | Control group | Experimental group | Control group | |||||
| ALT (U/L) | 17.14±10.07 | 17.23±9.91 | 0.690 | 25.72±23.11 | 29.59±36.13 | 0.070 | 25.57±18.57 | 32.81±43.85 | 0.053 | 26.79±24.70 | 30.95±60.82 | 0.583 |
| AST (U/L) | 19.20±7.32 | 19.42±9.17 | 0.678 | 26.44±30.33 | 27.96±29.42 | 0.018 | 24.69±11.23 | 32.04±45.33 | 0.030 | 25.21±15.74 | 30.41±38.74 | 0.064 |
| TBIL (μmol/L) | 10.64±5.48 | 10.83±6.14 | 0.811 | 8.88±4.97 | 9.18±4.74 | 0.287 | 9.58±4.51 | 10.15±5.93 | 0.715 | 10.25±4.47 | 10.42±6.23) | 0.515 |
| DBIL (μmol/L) | 4.20±3.03 | 4.01±2.45 | 0.334 | 3.69±3.31 | 5.90±25.02 | 0.551 | 3.69±2.05 | 4.03±2.78 | 0.466 | 3.86±1.90 | 5.40±19.12 | 0.593 |
| AKP (U/L) | 75.48±26.75 | 77.27±25.73 | 0.263 | 79.05±27.66 | 84.66±54.69 | 0.116 | 77.42±24.36 | 83.21±37.18 | 0.094 | 76.49±25.82 | 85.99±32.01 | 0.001 |
| TP (g/L) | 70.44±9.46 | 69.91±7.59 | 0.983 | 71.31±10.74 | 70.89±9.14 | 0.241 | ||||||
| ALB (g/L) | 40.88±5.87 | 41.32±6.14 | 0.533 | 42.89±5.60 | 43.14±6.01 | 0.754 | ||||||